148 related articles for article (PubMed ID: 10568693)
1. Dose-dependent localization of TCDD in isolated centrilobular and periportal hepatocytes.
Santostefano MJ; Richardson VM; Walker NJ; Blanton J; Lindros KO; Lucier GW; Alcasey SK; Birnbaum LS
Toxicol Sci; 1999 Nov; 52(1):9-19. PubMed ID: 10568693
[TBL] [Abstract][Full Text] [Related]
2. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.
Walker NJ; Crofts FG; Li Y; Lax SF; Hayes CL; Strickland PT; Lucier GW; Sutter TR
Carcinogenesis; 1998 Mar; 19(3):395-402. PubMed ID: 9525272
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
4. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
Santostefano MJ; Ross DG; Savas U; Jefcoate CR; Birnbaum LS
Biochem Biophys Res Commun; 1997 Apr; 233(1):20-4. PubMed ID: 9144388
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of TCDD differs between the liver, lungs, and kidneys after acute and subchronic exposure: species/dose comparisons and possible mechanism.
Santostefano MJ; Johnson KL; Whisnant NA; Richardson VM; DeVito MJ; Diliberto JJ; Birnbaum LS
Fundam Appl Toxicol; 1996 Dec; 34(2):265-75. PubMed ID: 8954756
[TBL] [Abstract][Full Text] [Related]
7. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.
Andersen ME; Birnbaum LS; Barton HA; Eklund CR
Toxicol Appl Pharmacol; 1997 May; 144(1):145-55. PubMed ID: 9169078
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
9. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
10. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
Santostefano MJ; Wang X; Richardson VM; Ross DG; DeVito MJ; Birnbaum LS
Toxicol Appl Pharmacol; 1998 Aug; 151(2):294-310. PubMed ID: 9707506
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice.
Abdelhamid G; Amara IE; Anwar-Mohamed A; El-Kadi AO
Arch Toxicol; 2013 Aug; 87(8):1531-43. PubMed ID: 23423713
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
13. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
14. Altered thyroxin and retinoid metabolic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in aryl hydrocarbon receptor-null mice.
Nishimura N; Yonemoto J; Miyabara Y; Fujii-Kuriyama Y; Tohyama C
Arch Toxicol; 2005 May; 79(5):260-7. PubMed ID: 15902423
[TBL] [Abstract][Full Text] [Related]
15. Regulation of rat carboxylesterase expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a dose-dependent decrease in mRNA levels but a biphasic change in protein levels and activity.
Yang D; Li Y; Yuan X; Matoney L; Yan B
Toxicol Sci; 2001 Nov; 64(1):20-7. PubMed ID: 11606798
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2.
Mahajan SS; Rifkind AB
Toxicol Appl Pharmacol; 1999 Feb; 155(1):96-106. PubMed ID: 10036222
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
19. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
[TBL] [Abstract][Full Text] [Related]
20. Modulation of aryl hydrocarbon receptor-regulated enzymes by trimethylarsine oxide in C57BL/6 mice: In vivo and in vitro studies.
Elshenawy OH; El-Kadi AO
Toxicol Lett; 2015 Oct; 238(1):17-31. PubMed ID: 26144063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]